ClassID:

91831

C07C53/18 - CPC Classification

Classification description:

Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen; Halogenated acetic acids containing fluorine

Recent Application in this class:
#1
20250171398
2025-05-29

COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS

#2
20250129087
2025-04-24

SALT CRYSTALS

#3
20240252863
2024-08-01

FLEXIBLE DRY SPRINKLER HAVING A DIFFERENTIAL PRESSURE CONTROLLER

#4
20240059724
2024-02-22

DEVICE AND CASSETTE FOR PERFORMING A PLURALITY OF SYNTHESIS PROCESSES OF PREPARING A RADIOPHARMACEUTICAL IN SERIES

#5
20230330464
2023-10-19

Flexible dry sprinkler having a differential pressure controller

#6
20230310643
2023-10-05

EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS

#7
20230174562
2023-06-08

RADIO-AND CHEMO-PROTECTIVE COMPOUNDS

#8
20230110165
2023-04-13

Substituted Imidazo[4,5-c]pyridine Compounds and Compositions Thereof

#9
20230024422
2023-01-26

RESIST TOPCOAT COMPOSITION, AND METHOD OF FORMING PATTERNS USING THE COMPOSITION

#10
20220396551
2022-12-15

EBNA1 inhibitors and their method of use

#11
20220073477
2022-03-10

KDM1A inhibitors for the treatment of disease

#12
20220017459
2022-01-20

COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS

#13
20210188855
2021-06-24

Compounds with activity as inhibitors of the epithelial sodium channel (ENaC)

#14
20210024693
2021-01-28

Alkoxylation methods

#15
20200361928
2020-11-19

Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections

#16
20200347059
2020-11-05

Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors

#17
20200283397
2020-09-10

KDM1A inhibitors for the treatment of disease

#18
20200262835
2020-08-20

Substituted imidazo[4,5-c]pyridine compounds and compositions thereof

#19
20200223778
2020-07-16

Reduction of content of carboxylic acids and derivatives thereof in oleum, disulfuric acid or concentrated sulfuric acid

#20
20200181078
2020-06-11

EBNA1 inhibitors and their method of use

#21
20200148646
2020-05-14

6-SUBSTITUTED AND 7-SUBSTITUTED MORPHINAN ANALOGS AND THE USE THEREOF

#22
20200071313
2020-03-05

Heteroaryl-substituted sulfonamide compounds and their use as sodium channel inhibitors

#23
20200002335
2020-01-02

Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors

#24
20190276487
2019-09-12

Device and cassette for performing a plurality of synthesis processes of preparing a radiopharmaceutical in series

#25
20190218249
2019-07-18

Process for purification of carfilzomib intermediate

#26
20190169193
2019-06-06

Method of treatment using substituted imidazo[1,2b]pyridazine compounds

#27
20190071436
2019-03-07

Bicyclic aryl monobactam compounds and methods of use thereof for the treatment of bacterial infections

#28
20190031618
2019-01-31

BENZIMIDAZOLE DERIVATIVES USEFUL AS CB-1 INVERSE AGONISTS

#29
20190002470
2019-01-03

Bicyclic azaheterocyclobenzylamines as PI3K inhibitors

#30
20180346496
2018-12-06

Multi-branched cationic phosphonium salt, forward osmosis extract employing the same and forward osmosis seawater desalination process

#31
20180327421
2018-11-15

5-HT3 receptor antagonists

#32
20180319829
2018-11-08

Phosphinic peptide derivatives for use as MMP-12 inhibitors

#33
20180312474
2018-11-01

KDM1A inhibitors for the treatment of disease

#34
20180217113
2018-08-02

Method for analyzing enantiomer

#35
20180194763
2018-07-12

Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors

#36
20180186808
2018-07-05

Nargenicin compounds and uses thereof as antibacterial agents

#37
20180155297
2018-06-07

Inhibitors of ACK1/TNK2 tyrosine kinase

#38
20180118774
2018-05-03

Method of performing a plurality of synthesis processes of preparing a radiopharmaceutical in series, a device and cassette for performing this method

#39
20180116219
2018-05-03

Herbicidal compounds

#40
20180105678
2018-04-19

Chemical amplification in self-strengthening materials

#41
20180086699
2018-03-29

EBNA1 inhibitors and their method of use

#42
20180072758
2018-03-15

5HT3 RECEPTOR ANTAGONISTS

#43
20180002314
2018-01-04

2-(pyrazin-2-ylcarbonylaminomethyl) benzimidazolium compounds as epithelial sodium channel inhibitors

#44
20170360785
2017-12-21

Pyrimidine FGFR4 inhibitors

#45
20170355669
2017-12-14

Compositions, methods, and systems for the synthesis and use of imaging agents

#46
20170313732
2017-11-02

Annelated phenoxyacetamides

#47
20170305924
2017-10-26

Nargenicin compounds and uses thereof as antibacterial agents

#48
20170275222
2017-09-28

Process for the functionalization of heteroalkanes and arenes

#49
20170260201
2017-09-14

5-HT3 receptor antagonists

#50
20170057929
2017-03-02

Benzimidazole derivatives useful as CB-1 inverse agonists

#51
20170050992
2017-02-23

NOVEL ANNELATED PHENOXYACETAMIDES

#52
20170029439
2017-02-02

Macrocyclic compounds

#53
20170029386
2017-02-02

N-alkoxyamide conjugates as imaging agents

#54
20170007601
2017-01-12

Pyrimidine FGFR4 inhibitors

#55
20160362362
2016-12-15

Compositions, methods, and systems for the synthesis and use of imaging agents

#56
20160346402
2016-12-01

Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)

#57
20160340360
2016-11-24

Dihydropyridone P1 as factor XIa inhibitors

#58
20160326172
2016-11-10

Compounds

#59
20160326095
2016-11-10

One-pot water-free ionic liquids synthesis using trialkyl orthoesters

#60
20160318872
2016-11-03

6-substituted and 7-substituted morphinan analogs and the use thereof

#61
20160311812
2016-10-27

ADENOSINE A1 AGONISTS AS MEDICAMENTS FOR KIDNEY DISORDERS

#62
20160304518
2016-10-20

Substituted aza-bicyclic imidazole derivatives useful TRPM8 receptor modulators

#63
20160297815
2016-10-13

7-azaindole or 4,7-diazaindole derivatives as IKKϵ epsilon and TBK1 inhibitor and pharmaceutical composition comprising same

#64
20160297758
2016-10-13

Pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

#65
20160289196
2016-10-06

Pyrazole derivatives as TNIK, IKKϵ and TBK1 inhibitor and pharmaceutical composition comprising same

#66
20160289185
2016-10-06

EBNA1 inhibitors and their method of use

#67
20160264580
2016-09-15

Bicyclic azaheterocyclobenzylamines as PI3K inhibitors

#68
20160264553
2016-09-15

GDF-8 inhibitors

#69
20160251373
2016-09-01

5-HT3 receptor antagonists

#70
20160251357
2016-09-01

Method of treatment using substituted imidazo[1,2b]pyridazine compounds

#71
20160237043
2016-08-18

KDM1A inhibitors for the treatment of disease

#72
20160235727
2016-08-18

Pyrrolidine derived beta 3 adrenergic receptor agonists

#73
20160221953
2016-08-04

3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use

#74
20160215016
2016-07-28

SYNTHESIS OF PEPTIDE EPOXY KETONES

#75
20160185801
2016-06-30

5-HT3 receptor antagonists

#76
20160185737
2016-06-30

N-alkoxyamide conjugates as imaging agents

#77
20160176826
2016-06-23

Inhibitors of ACK1/TNK2 tyrosine kinase

#78
20160137636
2016-05-19

Bicyclic sulfonamide compounds as sodium channel inhibitors

#79
20160130237
2016-05-12

Pyrimidine FGFR4 inhibitors

#80
20160102075
2016-04-14

Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors

#81
20160046626
2016-02-18

Bicyclic sulfonamide compounds as sodium channel inhibitors

#82
20160046622
2016-02-18

Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors

#83
20160046602
2016-02-18

Inhibitors of c-fms kinase

#84
20160024067
2016-01-28

Fluorescent compounds and uses thereof

#85
20160002268
2016-01-07

Zinc complex

#86
20150361037
2015-12-17

Acylguanidines for treating osteoarthritis

#87
20150353507
2015-12-10

4-amino substituted condensed pyrimidine compounds as PDE4 inhibitors

#88
20150329537
2015-11-19

CDK9 INHIBITORS IN THE TREATMENT OF MIDLINE CARCINOMA

#89
20150203487
2015-07-23

Azabenzimidazole tetrahydrofuran derivatives

#90
20150137666
2015-05-21

Reactive ionic liquid, and ion-immobilized metal oxide particle, ion-immobilized elastomer, and transducer using same

#91
20150105519
2015-04-16

Acid salt forms of polymer-drug conjugates and alkoxylation methods

#92
20150094465
2015-04-02

N-alkoxyamide conjugates as imaging agents

#93
20150080397
2015-03-19

Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors

#94
20150065567
2015-03-05

1-PHENYLALKANECARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND MULTIPLE SCLEROSIS

#95
20150045326
2015-02-12

Pyrazine amide compounds

#96
20150011574
2015-01-08

(2-heteroarylamino) succinic acid derivatives

#97
20150011511
2015-01-08

Heteroarylcarboxylic acid ester derivative

#98
20140371201
2014-12-18

Bicyclic sulfonamide compounds as sodium channel inhibitors

#99
20140323487
2014-10-30

Novel Compounds As Antagonists Or Inverse Agonists At Opioid Receptors

#100
20140303167
2014-10-09

CDK9 INHIBITORS IN THE TREATMENT OF MIDLINE CARCINOMA

#101
20140080790
2014-03-20

Heteroarylcarboxylic acid ester derivative

#102
20140066408
2014-03-06

Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives

#103
20140057912
2014-02-27

Pyrimidine-4,6-diamine derivatives as PI3K inhibitors

#104
20130231359
2013-09-05

Salt form of a multi-arm polymer-drug conjugate

#105
20130150290
2013-06-13

Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides

#106
20130150289
2013-06-13

Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides

#107
20130149244
2013-06-13

Compositions, methods, and systems for the synthesis and use of imaging agents

#108
20130143909
2013-06-06

Acid Salt Forms of Polymer-Drug Conjugates and Alkoxylation Methods

#109
20130072491
2013-03-21

Prophylactic or therapeutic agent for diabetes or obesity

#110
20120283222
2012-11-08

Heteroarylcarboxylic acid ester derivative

#111
20120190892
2012-07-26

Process for the preparation of a halogenoacetyl fluoride and its derivatives

#112
20120184559
2012-07-19

Compounds that are useful for improving pharmacokinetics

#113
20120172601
2012-07-05

Zinc cluster

#114
20120123159
2012-05-17

Method for preparing difluoroacetic acid

#115
20110306587
2011-12-15

Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors

#116
20110245206
2011-10-06

Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives

#117
20110218197
2011-09-08

Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators

#118
20110166385
2011-07-07

Method for separating a carboxylic acid in salified form bearing at least one halogen atom

#119
20110166122
2011-07-07

Substituted imidazo[1,2b]pyridazine compounds as Trk kinase inhibitors

#120
20110124559
2011-05-26

Compounds as antagonists or inverse agonists at opioid receptors

#121
20110098479
2011-04-28

CONDENSATION REACTION BY METAL CATALYST

#122
20110065955
2011-03-17

Method for preparing difluoroacetic acid and salts thereof

#123
20110005915
2011-01-13

METHOD FOR RECOVERING FLUOROCARBOXYLIC ACIDS

#124
20100326277
2010-12-30

Piperazinium trifluoroacetate compound and carbon dioxide absorbent using the same

#125
20100280248
2010-11-04

Compounds that are useful for improving pharmacokinetics

#126
20100041904
2010-02-18

Antioxidant inflammation modulators: C-17 homologated oleanolic acid derivatives

#127
20090253905
2009-10-08

PROCESS FOR THE PREPARATION OF ONIUM SALTS WITH ALKYL- OR ARYLSULFONATE ANIONS OR ALKYL- OR ARYLCARBOXYLATE ANIONS HAVING A LOW HALIDE CONTENT

#128
20090252676
2009-10-08

N-alkoxyamide conjugates as imaging agents

#129
20090198070
2009-08-06

Condensation reaction by metal catalyst

#130
20090105156
2009-04-23

Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides

#131
20090028791
2009-01-29

Dichloroacetate Analogs as Imaging Agents

#132
20070249649
2007-10-25

Inhibitors of C-FMS kinase

#133
20060199851
2006-09-07

Compounds that are useful for improving pharmacokinetics

#134
20050065364
2005-03-24

Process for production of acetyl anhydrides and optionally acetic acid from methane and carbon dioxide

#135
20050020856
2005-01-27

Process for production of acetyl anhydrides and optionally acetic acid from methane and carbon dioxide